In addition, several clinical trials support the experimental laboratory findings that LCN2 is a crucial component of neuroinflammation that mediates brain injury in cerebral ischemia and other pathological conditions (Chan et al., 2012; Fernandez-Cadenas et al., 2013). This evidence concerns the gene LCN2 and Cerebral ischemia.